Latest Stereotactic radiation therapy Stories
ATLANTA and VANCOUVER, B.C., Canada, July 26, 2011 /PRNewswire/ -- Encompassing virtually every aspect of modern cancer management, Elekta (booth # 401) will demonstrate not only the depth and breadth of its offerings, but its commitment to maximize safety in radiation therapy delivery at the joint 2011 AAPM/COMP meeting.
ATLANTA, July 18, 2011 /PRNewswire/ -- Among the many new features of MonacoÂ® 3.0, Dynamic Conformal Arc (DCA) Therapy provides clinicians with a simple way to deliver highly conformal stereotactic plans by using the multi-leaf collimator (MLC) to dynamically conform around a target as the treatment beam rotates around the patient.
In a multicenter clinical trial, UT Southwestern Medical Center researchers have found that higher doses of stereotactic radiation therapy requiring fewer treatments are safe and effective for patients with low-to-intermediate-risk prostate cancer.
A new type of targeted radiation therapy, stereotactic radiation therapy, is just as good as surgery for patients 75 and older with early-stage lung cancer, according to this study.
HANGZHOU, China, Oct. 18 /PRNewswire/ -- Lung cancer is a major and growing global epidemic, according to Billy W. Loo, Jr., M.D., assistant professor of radiation oncology at Stanford University in Palo Alto, California. Dr.
There is yet no straightforward way to determine the optimal dose level and treatment schedules for high-dose radiation therapies such as stereotactic radiation therapy, which is used to treat brain and lung cancer, or for high-dose brachytherapy for prostate and other cancers.
NEW YORK (Reuters Health) - For patients with cancer that has spread to the brain from other sites, adding whole-brain radiation therapy to focused radiation does not seem to improve survival, doctors in Japan report.
Shaped-beam radiation therapy is a promising treatment for life-threatening metastatic liver tumors, according to researchers at the University of Rochester Medical Center who report an 88 percent success rate for controlling the lesions. This is the first evidence that doctors can treat these tumors with radiation, and the results doubled the average length of survival.